Director, Value & Access

Lead development and execution of access strategies for oncology diagnostics and computational pathology solutions, translating clinical and economic value into coding, coverage, and reimbursement outcomes. Shape payer engagement to secure medical policy coverage and payment levels across commercial, private, and government payers while anticipating access risks. Embed access requirements into innovation, launch planning, and portfolio strategy, serving as the Value & Access voice in go-to-market decisions across the Danaher Oncology portfolio. Influence cross-functional teams in Product Development, Medical, Scientific Affairs, and Regulatory to ensure alignment of global access strategies across U.S., Europe, Asia, and LATAM. This role reports to the Vice President, Value & Access, Diagnostics, within the Chief Innovation Office, offering fully remote or office-based flexibility.